As most advisors are well aware, high stock prices have pushed down the market’s dividend yield. Barron’s ran a screen for ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue ...